My first Magazine Global-CRISPR-Market-Size-Status-and-Forecast-2022 | Page 3

3.2.3 Products, Services and Solutions
3.2.4 CRISPR Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Caribou Biosciences
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 CRISPR Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 CRISPR Therapeutics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 CRISPR Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Intellia Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 CRISPR Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Cellectis
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 CRISPR Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Horizon Discovery Plc
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 CRISPR Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Sigma Aldrich
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 CRISPR Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Precision Biosciences
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 CRISPR Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Genscript
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 CRISPR Revenue (Value) (2012-2017)